April 7, 2021 – OpSens Inc. (Quebec City, Canada), a medical device cardiology-focused company, has been awarded an Innovative Technology contract from Vizient. It was awarded based on the recommendation of OptoWire III, a guidewire to diagnose and treat coronary disease, by hospital experts who serve on one of Vizient’s member-led councils. The OpSens OptoWire III allows navigation through complex anatomies, delivery of a stent without guidewire exchange, choices among different hyperemic and resting indices to assess coronary physiology, and confirmation of treatment with reliable post-PCI measurements.